Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aura Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −1 vs. Q2 2022
- Shares held
- 16.3M
- +523.3K (+3.3%) vs. Q2 2022
- Total value
- $295.7M
- +$71.9M (+32.1%) vs. Q2 2022
- New holders
- 2
- 24 more added
- Sold out
- 3
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 103 | $2.00K | 0.00% | +91+758.3% | Added |
| Royal Bank of Canada | 223 | $4.00K | 0.00% | +120+116.5% | Added |
| Wells Fargo & Company | 310 | $6.00K | 0.00% | −120−27.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,262 | $23.0K | 0.00% | −2,687−68.0% | Reduced |
| STRS Ohio | 1,300 | $23.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,280 | $23.2K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,374 | $24.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 2,256 | $41.0K | 0.00% | +1,394+161.7% | Added |
| Amalgamated Bank | 2,941 | $53.0K | 0.00% | +45+1.6% | Added |
| BNP Paribas Arbitrage, SA | 5,821 | $105.5K | 0.00% | +5,821 | New |
| California State Teachers Retirement System | 7,233 | $131.0K | 0.00% | −603−7.7% | Reduced |
| Deutsche Bank AG | 8,035 | $146.0K | 0.00% | −1,226−13.2% | Reduced |
| American International Group, Inc. | 8,700 | $158.0K | 0.00% | +123+1.4% | Added |
| JPMorgan Chase & Co | 10,013 | $181.0K | 0.00% | +215+2.2% | Added |
| Water Island Capital LLC | 10,700 | $194.0K | 0.01% | −3,841−26.4% | Reduced |
| MetLife Investment Management | 11,026 | $199.8K | 0.00% | 00.0% | Unchanged |
| Dynamic Technology Lab Private Ltd | 11,961 | $217.0K | 0.02% | +11,961 | New |
| UBS Group AG | 12,267 | $222.0K | 0.00% | −4,053−24.8% | Reduced |
| UBS Oconnor LLC | 12,430 | $225.0K | 0.00% | −78,109−86.3% | Reduced |
| Captrust Financial Advisors | 13,414 | $243.0K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 14,472 | $262.0K | 0.00% | +120+0.8% | Added |
| Rhumbline Advisers | 22,339 | $405.0K | 0.00% | +1,626+7.9% | Added |
| Barclays PLC | 42,044 | $762.0K | 0.00% | −142−0.3% | Reduced |
| Bank of America Corp | 45,239 | $820.0K | 0.00% | +9,896+28.0% | Added |
| Charles Schwab Investment Management Inc | 47,003 | $852.0K | 0.00% | +3,994+9.3% | Added |
| Bank of New York Mellon Corp | 50,336 | $912.0K | 0.00% | +10,240+25.5% | Added |
| Morgan Stanley | 55,152 | $1.00M | 0.00% | +613+1.1% | Added |
| Nuveen Asset Management, LLC | 61,724 | $1.12M | 0.00% | +497+0.8% | Added |
| Northern Trust Corp | 145,101 | $2.63M | 0.00% | +12,409+9.4% | Added |
| Citigroup Inc | 149,740 | $2.71M | 0.00% | +26,552+21.6% | Added |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $3.81M | 1.38% | 00.0% | Unchanged |
| Regency Capital Management Inc. | 224,554 | $4.07M | 4.99% | −30,068−11.8% | Reduced |
| Geode Capital Management, LLC | 289,312 | $5.24M | 0.00% | +82,018+39.6% | Added |
| State Street Corp | 298,438 | $5.41M | 0.00% | +41,692+16.2% | Added |
| Nantahala Capital Management, LLC | 383,764 | $6.95M | 0.68% | +40,549+11.8% | Added |
| FMR LLC | 603,761 | $10.9M | 0.00% | +2900.0% | Added |
| Vanguard Group Inc | 605,884 | $11.0M | 0.00% | +170,709+39.2% | Added |
| BlackRock Inc. | 1,013,455 | $18.4M | 0.00% | +126,732+14.3% | Added |
| Rock Springs Capital Management LP | 1,015,757 | $18.4M | 0.48% | +6,943+0.7% | Added |
| Adage Capital Partners GP, L.L.C. | 1,451,201 | $26.3M | 0.07% | +174,582+13.7% | Added |
| Citadel Advisors LLC | 2,312,318 | $41.9M | 0.05% | +1590.0% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $55.1M | 22.93% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 4,112,870 | $74.5M | 1.43% | 00.0% | Unchanged |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −61,575−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,917−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |